Serum Ceramide Ratios Predict Cardiovascular Events in Patients With Type 2 Diabetes Independently From the Presence of Coronary Artery Disease

被引：0
|
作者：
Leiherer, Andreas
Muendlein, Axel
Saely, Christoph H.
Laaksonen, Reijo
Laaperi, Mitja
Vonbank, Alexander
Mader, Arthur
Fraunberger, Peter
Drexel, Heinz
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11024
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SERUM CERAMIDE RATIOS PREDICT CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES INDEPENDENTLY FROM THE PRESENCE OF CORONARY ARTERY DISEASE
    Leiherer, A.
    Muendlein, A.
    Saely, C. H.
    Laaksonen, R.
    Laaperi, M.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Fraunberger, P.
    Drexel, H.
    ATHEROSCLEROSIS, 2020, 315 : E224 - E224
  • [2] Serum Ceramide Ratios Predict Cardiovascular Events in Patients with Type 2 Diabetes Independently from the Presence of Coronary Artery Disease
    Leiherer, Andreas
    Muendlein, Axel
    Saely, Christoph H.
    Laaksonen, Rejo
    Laaperi, Mitja
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Fraunberger, Peter
    Drexel, Heinz
    DIABETES, 2019, 68
  • [3] Betatrophin Predicts Cardiovascular Events Independently from the Presence of Type 2 Diabetes and Coronary Artery Disease
    Leiherer, Andreas
    Muendlein, Axel
    Geiger, Kathrin
    Saely, Christoph H.
    Brandtner, Eva-Maria
    Ebner, Janine
    Larcher, Barbara
    Mader, Arthur
    Fraunberger, Peter
    Drexel, Heinz
    DIABETES, 2018, 67
  • [4] BETATROPHIN PREDICTS CARDIOVASCULAR EVENTS INDEPENDENTLY FROM THE PRESENCE OF TYPE 2 DIABETES AND CORONARY ARTERY DISEASE
    Leiherer, A.
    Luetjohann, D.
    Muendlein, A.
    Kathrin, G.
    Saely, C. H.
    Brandtner, E. M.
    Larcher, B.
    Mader, A.
    Fraunberger, P.
    Drexel, H.
    ATHEROSCLEROSIS, 2019, 287 : E62 - E62
  • [5] BETATROPHIN PREDICTS CARDIOVASCULAR EVENTS INDEPENDENTLY FROM THE PRESENCE OF TYPE 2 DIABETES AND CORONARY ARTERY DISEASE
    Leiherer, Andreas
    Luetjohann, Dieter
    Muendlein, Axel
    Geiger, Kathrin
    Saely, Christoph H.
    Brandtner, Eva-Maria
    Larcher, Barbara
    Mader, Arthur
    Fraunberger, Peter
    Drexel, Heinz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2061 - 2061
  • [6] Betatrophin predicts cardiovascular events independently from the presence of type 2 diabetes and coronary artery disease
    Leiherer, Andreas
    Muendlein, Axel
    Geiger, Kathrin
    Saely, Christoph H.
    Brandtner, Eva-Maria
    Ebner, Janine
    Larcher, Barbara
    Mader, Arthur
    Ebner, Karl-Martin
    Fraunberger, Peter
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 354 - 354
  • [7] Betatrophin predicts cardiovascular events independently from the presence of Type 2 Diabetes and coronary artery disease
    Leiherer, A.
    Muendlein, A.
    Geiger, K.
    Saely, C. H.
    Brandtner, E. -M.
    Ebner, J.
    Larcher, B.
    Mader, A.
    Ebner, K. -M.
    Fraunberger, Peter
    Drexel, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 58 - 58
  • [8] Betatrophin predicts cardiovascular events independently from the presence of type 2 diabetes and coronary artery disease
    Leiherer, A.
    Muendlein, A.
    Geiger, K.
    Saely, C. H.
    Brandtner, E. -M.
    Ebner, J.
    Larcher, B.
    Mader, A.
    Fraunberger, P.
    Drexel, H.
    DIABETOLOGIA, 2018, 61 : S287 - S287
  • [9] Serum resistin is associated with coronary artery disease and predicts major cardiovascular events in type 2 diabetes patients
    Menzaghi, C.
    Bacci, S.
    Salvemini, L.
    Powers, C.
    Fini, G.
    Rizza, S.
    Goheen, E.
    De Bonis, C.
    Kanagaki, A.
    Mangiacotti, D.
    Federici, M.
    Doria, A.
    Trischitta, V.
    DIABETOLOGIA, 2011, 54 : S58 - S58
  • [10] Albuminuria significantly predicts cardiovascular events in patients with type 2 diabetes independently from the baseline coronary artery state
    Rein, P.
    Saely, C. H.
    Zanolin, D.
    Vonbank, A.
    Drexel, H.
    EUROPEAN HEART JOURNAL, 2013, 34 : 963 - 964
12345